-
IHE Dashboard
- Holdings
iShares U.S. Pharmaceuticals ETF
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
JNJ Johnson & Johnson | 144.97 mm | 1.00 mm shares | 23.74 | Common equity | Long | USA |
LLY Eli Lilly and Company | 142.56 mm | 184.66 k shares | 23.35 | Common equity | Long | USA |
PFE Pfizer Inc. | 30.91 mm | 1.17 mm shares | 5.06 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 29.35 mm | 518.96 k shares | 4.81 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 29.32 mm | 294.73 k shares | 4.80 | Common equity | Long | USA |
VTRS Viatris Inc. | 28.71 mm | 2.31 mm shares | 4.70 | Common equity | Long | USA |
ZTS Zoetis Inc. | 27.04 mm | 165.95 k shares | 4.43 | Common equity | Long | USA |
RPRX Royalty Pharma plc | 22.49 mm | 881.63 k shares | 3.68 | Common equity | Long | UK |
ITCI Intra-Cellular Therapies, Inc. | 19.00 mm | 227.51 k shares | 3.11 | Common equity | Long | USA |
JAZZ Jazz Pharmaceuticals plc | 17.18 mm | 139.48 k shares | 2.81 | Common equity | Long | Ireland |
BLACKROCK CASH FUNDS INSTITUTIONAL FUND SL AGENCY | 15.51 mm | 15.50 mm shares | 2.54 | Short-term investment vehicle | Long | USA |
ELAN Elanco Animal Health Incorporated | 13.81 mm | 1.14 mm shares | 2.26 | Common equity | Long | USA |
CORT Corcept Therapeutics Incorporated | 10.84 mm | 215.17 k shares | 1.78 | Common equity | Long | USA |
PBH Prestige Consumer Healthcare Inc. | 8.90 mm | 113.99 k shares | 1.46 | Common equity | Long | USA |
OGN Organon & Co. | 8.87 mm | 594.25 k shares | 1.45 | Common equity | Long | USA |
PRGO Perrigo Company plc | 8.09 mm | 314.79 k shares | 1.33 | Common equity | Long | Ireland |
AXSM Axsome Therapeutics, Inc. | 7.95 mm | 93.96 k shares | 1.30 | Common equity | Long | USA |
LGND Ligand Pharmaceuticals Incorporated | 4.67 mm | 43.61 k shares | 0.77 | Common equity | Long | USA |
SUPN Supernus Pharmaceuticals, Inc. | 4.61 mm | 127.43 k shares | 0.75 | Common equity | Long | USA |
TARS Tarsus Pharmaceuticals, Inc. | 4.45 mm | 80.28 k shares | 0.73 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 3.62 mm | 135.48 k shares | 0.59 | Common equity | Long | USA |
WVE Wave Life Sciences Ltd. | 3.35 mm | 271.04 k shares | 0.55 | Common equity | Long | Singapore |
AMPH Amphastar Pharmaceuticals, Inc. | 3.21 mm | 86.56 k shares | 0.53 | Common equity | Long | USA |
HRMY Harmony Biosciences Holdings, Inc. | 3.03 mm | 88.18 k shares | 0.50 | Common equity | Long | USA |
ARVN Arvinas, Inc. | 2.83 mm | 147.53 k shares | 0.46 | Common equity | Long | USA |
AMRX Amneal Pharmaceuticals, Inc. | 2.72 mm | 343.30 k shares | 0.45 | Common equity | Long | USA |
OCUL Ocular Therapeutix, Inc. | 2.51 mm | 293.92 k shares | 0.41 | Common equity | Long | USA |
HROW Harrow Health, Inc. | 2.37 mm | 70.69 k shares | 0.39 | Common equity | Long | USA |
INVA Innoviva, Inc. | 2.21 mm | 127.15 k shares | 0.36 | Common equity | Long | USA |
COLL Collegium Pharmaceutical, Inc. | 2.13 mm | 74.44 k shares | 0.35 | Common equity | Long | USA |
ANIP ANI Pharmaceuticals, Inc. | 2.12 mm | 38.33 k shares | 0.35 | Common equity | Long | USA |
NMRA Neumora Therapeutics, Inc. Common Stock | 2.06 mm | 193.93 k shares | 0.34 | Common equity | Long | USA |
PCRX Pacira BioSciences, Inc. | 2.01 mm | 106.59 k shares | 0.33 | Common equity | Long | USA |
PLRX Pliant Therapeutics, Inc. | 1.63 mm | 123.71 k shares | 0.27 | Common equity | Long | USA |
ELVN Enliven Therapeutics, Inc. | 1.57 mm | 69.72 k shares | 0.26 | Common equity | Long | USA |
NUVB Nuvation Bio Inc. | 1.56 mm | 586.95 k shares | 0.26 | Common equity | Long | USA |
OMER Omeros Corporation | 1.32 mm | 133.37 k shares | 0.22 | Common equity | Long | USA |
Liquidia Corporation | 1.28 mm | 109.09 k shares | 0.21 | Common equity | Long | USA |
EOLS Evolus, Inc. | 1.26 mm | 113.68 k shares | 0.21 | Common equity | Long | USA |
MNMD Mind Medicine (MindMed) Inc. | 1.06 mm | 151.90 k shares | 0.17 | Common equity | Long | Canada |
PHAT Phathom Pharmaceuticals, Inc. | 830.64 k | 102.30 k shares | 0.14 | Common equity | Long | USA |
TBPH Theravance Biopharma, Inc. | 755.99 k | 80.34 k shares | 0.12 | Common equity | Long | Cayman Islands |
BLACKROCK CASH FUNDS TREASURY | 717.83 k | 717.83 k shares | 0.12 | Short-term investment vehicle | Long | USA |
RVNC Revance Therapeutics, Inc. | 631.27 k | 207.66 k shares | 0.10 | Common equity | Long | USA |
XAV HEALTH CARE MAR25 | -1.73 k | 5.00 contracts | -0.00 | Equity derivative | N/A | USA |